Zi-Qi Zhou

670 total citations
16 papers, 515 citations indexed

About

Zi-Qi Zhou is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Zi-Qi Zhou has authored 16 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Zi-Qi Zhou's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Zi-Qi Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Zi-Qi Zhou collaborates with scholars based in China and Hong Kong. Zi-Qi Zhou's co-authors include Jian‐Chuan Xia, De-Sheng Weng, Qiu-Zhong Pan, Chang-Long Chen, Xiaofei Zhang, Jing-Jing Zhao, Qian Zhu, Hong-Xia Zhang, Shan-Shan Jiang and Yan Tang and has published in prestigious journals such as RSC Advances, Journal of Hematology & Oncology and Oncotarget.

In The Last Decade

Zi-Qi Zhou

15 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zi-Qi Zhou China 14 216 168 150 120 88 16 515
Zhangfu Yang China 18 139 0.6× 288 1.7× 103 0.7× 232 1.9× 97 1.1× 44 795
Kim de Lange Netherlands 10 218 1.0× 76 0.5× 136 0.9× 44 0.4× 113 1.3× 18 435
Kezheng Wang China 13 141 0.7× 140 0.8× 85 0.6× 113 0.9× 53 0.6× 39 554
Xinliang Zhou China 11 103 0.5× 199 1.2× 161 1.1× 75 0.6× 27 0.3× 20 476
Akira Fukunaga Japan 10 635 2.9× 217 1.3× 385 2.6× 124 1.0× 98 1.1× 30 975
Jiro Abe Japan 12 149 0.7× 308 1.8× 69 0.5× 274 2.3× 167 1.9× 47 732
Takashi Mitamura Japan 20 192 0.9× 428 2.5× 67 0.4× 321 2.7× 59 0.7× 59 1.0k
Bingxin Gu China 14 273 1.3× 85 0.5× 65 0.4× 132 1.1× 94 1.1× 47 673

Countries citing papers authored by Zi-Qi Zhou

Since Specialization
Citations

This map shows the geographic impact of Zi-Qi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Qi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Qi Zhou more than expected).

Fields of papers citing papers by Zi-Qi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Qi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Qi Zhou. The network helps show where Zi-Qi Zhou may publish in the future.

Co-authorship network of co-authors of Zi-Qi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Qi Zhou. A scholar is included among the top collaborators of Zi-Qi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Qi Zhou. Zi-Qi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Zhang, Jingyang, Zi-Qi Zhou, Zhibing Zhang, et al.. (2021). Recent development of chemically complex metallic glasses: from accelerated compositional design, additive manufacturing to novel applications. CityU Scholars. 1(1). 12001–12001. 32 indexed citations
3.
Zhu, Qian, Hao Hu, De-Sheng Weng, et al.. (2020). Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Journal of Hematology & Oncology. 13(1). 2–2. 51 indexed citations
4.
Zhou, Zi-Qi, Jing-Jing Zhao, Qiu-Zhong Pan, et al.. (2019). PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer. Journal for ImmunoTherapy of Cancer. 7(1). 228–228. 27 indexed citations
5.
Zhao, Jing-Jing, Zi-Qi Zhou, Qiu-Zhong Pan, et al.. (2019). <p>IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 6691–6702. 24 indexed citations
6.
Zhao, Jing-Jing, Chang-Long Chen, Hong-Xia Zhang, et al.. (2018). Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis. Journal of Cancer. 9(22). 4204–4214. 4 indexed citations
7.
Zhou, Zi-Qi, Xiaofei Zhang, Chang-Long Chen, et al.. (2017). Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma. Journal of Cancer. 8(18). 3812–3827. 13 indexed citations
8.
Zhu, Qian, Hao Hu, De-Sheng Weng, et al.. (2017). Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC. BMC Cancer. 17(1). 412–412. 22 indexed citations
9.
Chen, Chang-Long, Qiu-Zhong Pan, De-Sheng Weng, et al.. (2017). Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors. OncoImmunology. 7(4). e1417721–e1417721. 42 indexed citations
10.
Chen, Chang-Long, Ying Wang, Chun-yu Huang, et al.. (2017). IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. OncoImmunology. 7(1). e1373234–e1373234. 57 indexed citations
11.
Chen, Chang-Long, Qiu-Zhong Pan, Jing-Jing Zhao, et al.. (2016). PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma. OncoImmunology. 5(7). e1176653–e1176653. 51 indexed citations
12.
Jiang, Shan-Shan, De-Sheng Weng, Long Jiang, et al.. (2016). The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. Journal of Cancer. 7(6). 626–632. 59 indexed citations
13.
Chen, Chang-Long, Ying Wang, Qiu-Zhong Pan, et al.. (2016). Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma. Oncotarget. 7(13). 16248–16261. 22 indexed citations
14.
Zhang, Hong-Xia, Shan-Shan Jiang, Xiaofei Zhang, et al.. (2015). Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma. Oncotarget. 6(33). 34800–34817. 48 indexed citations
15.
Wang, Ying, Chang-Long Chen, Qiu-Zhong Pan, et al.. (2015). Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. 7(5). 6323–6334. 26 indexed citations
16.
Xu, Zheng‐Long, Biao Zhang, Zi-Qi Zhou, et al.. (2014). Carbon nanofibers containing Si nanoparticles and graphene-covered Ni for high performance anodes in Li ion batteries. RSC Advances. 4(43). 22359–22366. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhangfu Yang Breakdown of academic impact, for papers by Kim de Lange Breakdown of academic impact, for papers by Kezheng Wang Breakdown of academic impact, for papers by Xinliang Zhou Breakdown of academic impact, for papers by Akira Fukunaga Breakdown of academic impact, for papers by Jiro Abe Breakdown of academic impact, for papers by Takashi Mitamura Breakdown of academic impact, for papers by Bingxin Gu
Rankless by CCL
2026